Sobue, A., Komine, O., Endo, F., Kakimi, C., Miyoshi, Y., Kawade, N., . . . Yamanaka, K. (2024, November). Microglial cannabinoid receptor type II stimulation improves cognitive impairment and neuroinflammation in Alzheimer’s disease mice by controlling astrocyte activation. Cell Death and Disease.
Chicagoスタイル(17版)引用形式Sobue, Akira, et al. "Microglial Cannabinoid Receptor Type II Stimulation Improves Cognitive Impairment and Neuroinflammation in Alzheimer’s Disease Mice by Controlling Astrocyte Activation." Cell Death and Disease Nov. 2024.
MLA(9版)引用形式Sobue, Akira, et al. "Microglial Cannabinoid Receptor Type II Stimulation Improves Cognitive Impairment and Neuroinflammation in Alzheimer’s Disease Mice by Controlling Astrocyte Activation." Cell Death and Disease, Nov. 2024.